🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impact of Mulstidisciplinary Medication Assessment Review in Surgery Departments

RecruitingNAAges 65 Years - anyAllCentre Hospitalier Universitaire de Nīmes
NCT03827031 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The presence of a clinical pharmacist (for their pharmacological expertise) and a general practitioner (for their somatic expertise) in surgery departments would contribute to improve the management of medications in elderly patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * The patient (or their representative) has given his consent and signed the consent form. * The patient is affiliated to a health insurance programme. * The patient is at least 65 years old (≥) treated by at least (≥) five medications for at least (≥) 6 months * The patient is available for a follow-up of 3 months. * The patient is hospitalized in the surgery department. * Patient with a Trivalle score greater than or equal to 2 (≥). * Patient living in a nursing home or going back home after hospitalization. Exclusion Criteria: * The subject is participating in another category I interventional study. * The subject is in an exclusion period determined by another study. * The subject is under safeguard of justice. * It is not possible to give the patient (or his/her trusted-person) informed information. * Palliative care
💊

What it tests

  • Mutlidisciplinary medication Review (MMR)
  • Mutlidisciplinary medication Review (MMR) with community pharmacist follow-up
📍

Where

4 sites
Chu de Grenoble
Grenoble, France
CHU de Montpellier
Montpellier, France
Nimes University Hospital
Nîmes, France
CHU de Toulouse
Toulouse, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy